Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.31 EUR | +0.87% | +5.96% | +60.42% |
May. 21 | NFL Biosciences receives positive feedback from the FDA | CF |
Apr. 12 | Global markets live: BP, Apple, Vodafone, Ford, Lockheed Martin... |
Sales 2023 | 200K 217K | Sales 2024 * | - | Capitalization | 22.21M 24.08M |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 | 111 x |
Net cash position 2023 * | 2.3M 2.49M | Net cash position 2024 * | 200K 217K | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 68.13% |
1 day | +0.87% | ||
1 week | +5.96% | ||
Current month | +25.54% | ||
1 month | +17.26% | ||
3 months | +13.51% | ||
6 months | +46.57% | ||
Current year | +60.42% |
Managers | Title | Age | Since |
---|---|---|---|
Bruno Lafont
FOU | Founder | - | 06-08-31 |
Ignacio Faus
CEO | Chief Executive Officer | - | 21-05-18 |
Guillaume Audema
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yannick Plétan
BRD | Director/Board Member | - | 21-05-18 |
Ignacio Faus
CEO | Chief Executive Officer | - | 21-05-18 |
Bruno Lafont
FOU | Founder | - | 06-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 2.31 | +0.87% | 25,558 |
24-05-23 | 2.29 | +5.05% | 120,001 |
24-05-22 | 2.18 | -1.36% | 36,706 |
24-05-21 | 2.21 | +1.14% | 142,298 |
24-05-20 | 2.185 | +0.23% | 18,981 |
Real-time Euronext Paris, May 24, 2024 at 11:35 am EDT
More quotesChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+60.42% | 24.1M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- ALNFL Stock